| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.07▲ | 1.07▲ | 1.08▼ | 1.02▲ | 1.00▲ |
| MA10 | 1.07▲ | 1.08▼ | 1.08▼ | 1.05▲ | 0.95▲ |
| MA20 | 1.08▼ | 1.08▼ | 1.05▲ | 0.98▲ | 1.13▼ |
| MA50 | 1.08▼ | 1.03▲ | 1.05▲ | 0.97▲ | 1.04▲ |
| MA100 | 1.04▲ | 1.05▲ | 1.01▲ | 1.15▼ | 1.48▼ |
| MA200 | 1.05▲ | 1.00▲ | 0.96▲ | 1.14▼ | 3.34▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.005▼ | 0.001▲ | 0.011▲ | -0.012▼ |
| RSI | 49.835▼ | 52.698▲ | 54.358▲ | 55.496▲ | 48.416▼ |
| STOCH | 23.611 | 41.667 | 40.791 | 56.696 | 46.644 |
| WILL %R | -50.000 | -55.556 | -66.667 | -25.000▲ | -45.890 |
| CCI | 13.333 | -24.561 | -62.172 | 65.444 | -13.060 |
|
Sunday, May 17, 2026 06:16 PM
Rani Therapeutics Holdings, Inc. Class A faces a significant listing risk after receiving a Nasdaq deficiency notice for failing to meet the $1.00 minimum bid price over 30 consecutive trading days.
|
|
Saturday, May 16, 2026 08:39 AM
Detailed price information for Rani Therapeutics Holdings Inc Cl A (RANI-Q) from The Globe and Mail including charting and trades.
|
|
Saturday, May 16, 2026 06:44 AM
Continued advancement of the ongoing Phase 1 study of RT-114 via RaniPill® for the treatment of obesity in collaboration with ProGen –- ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/05/26 | 1.10 | 1.10 | 1.06 | 1.075 | 535,632 |
| 21/05/26 | 1.06 | 1.11 | 1.05 | 1.07 | 995,076 |
| 20/05/26 | 0.9074 | 1.12 | 0.90 | 1.09 | 2,417,342 |
| 19/05/26 | 0.9622 | 0.9699 | 0.88 | 0.8844 | 1,280,563 |
| 18/05/26 | 1.06 | 1.12 | 0.96 | 0.9723 | 1,416,495 |
| 15/05/26 | 1.11 | 1.11 | 1.0601 | 1.08 | 988,703 |
| 14/05/26 | 1.06 | 1.14 | 1.045 | 1.11 | 1,570,259 |
| 13/05/26 | 1.10 | 1.10 | 1.045 | 1.05 | 856,327 |
| 12/05/26 | 1.08 | 1.12 | 1.02 | 1.10 | 1,092,699 |
| 11/05/26 | 1.00 | 1.11 | 0.9901 | 1.07 | 2,307,195 |
|
|
||||
|
|
||||
|
|